<DOC>
	<DOCNO>NCT01880866</DOCNO>
	<brief_summary>Pulmonary arterial hypertension ( PAH ) progressive disease result severe activity limitation death . There treatment PAH available medication expensive , difficult administer significant toxicity . ( - ) -Epicatechin non-toxic compound naturally occur food tea , wine chocolate . Clinical intervention study use dark chocolate normal volunteer subject risk establish cardiovascular disease demonstrate improvement peripheral coronary vascular endothelial function , blood pressure , lipid , glucose tolerance inflammatory marker . Our study intend examine hemodynamics effect purify ( - ) -epicatechin subject pulmonary arterial hypertension . We hypothesize purify ( - ) -epicatechin reduce pulmonary vascular resistance patient pulmonary arterial hypertension .</brief_summary>
	<brief_title>( - ) -Epicatechin Pulmonary Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>Male female age 18 old NYHA Class II ! V 6 minute walk distance &lt; 450 meter Outpatients suspect WHO group I PAH establish diagnosis WHO group I PAH undergo clinically indicate right heart catheterization Written inform consent obtain subject ability subject comply requirement study Pregnancy Breast feed Systolic blood pressure &lt; 100 &gt; 160 History migraine headache Allergy intolerance chocolate , tea wine Subject consider unsuitable study opinion investigator , nurse practitioner , study physician reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>PAH</keyword>
</DOC>